Genoskin appoints DR Nicolas Gaudenzio as chief scientific officer
World-renowned expert in immunology and allergic skin inflammation, Dr Nicolas Gaudenzio has just been appointed as CSO of ex vivo clinical testing specialist Genoskin. He also leads a research group at Inserm – the French National Institute of Health and Medical Research – in the field of skin neuro-immunology, inflammation and imaging
His expertise in skin immunology and imaging of the human immune system will guide Genoskin’s strategic shift towards immunology expert services for the pharmaceutical industry
Advent France Biotechnology appoints Sidonie Fabre as CFO
Sidonie Fabre’s extensive career in finance will help Advent France Biotechnology (AFB) strengthen financial structure – as growing VC firm
Lynred names Jean-Yves Dussaud as chief marketing officer
Advent France Biotechnology appoints Alejo Chorny, PhD, as operating partner and head of new Spanish operations
Accure Therapeutics strengthens scientific advisory board by appointing top-class scientists
Robocath bolsters Strategic Committee with appointment of Chantal Le Chat
Yposkesi welcomes Brian Mullan, PhD, as director of innovation, analytical and process development
PhysioStim appoints Dr. Bruno Le Grand as scientific advisor
